Reviewed against public sources on July 21, 2026
Published by Dirkes Medical, PLLC, the maker of Reductinn

Best tinnitus apps for relief in 2026.

This page compares five popular tinnitus apps using a transparent scorecard focused on scientific basis, evidence transparency, structure, sleep support, sound support, progress tracking, and whether access is recurring, limited-term, provider-only, or a low one-time unlock.

Disclosure

This comparison is published by Dirkes Medical, PLLC, the maker of Reductinn. Reductinn is one of the apps ranked here, and we score it against the same public-source criteria as every other app. We include our own product openly rather than leaving it out of the comparison.

1

Reductinn

CBT-first self-management

98

out of 100

4.9/5

$9.99

Current US App Store paid offer after 3 free days

2

Kalmeda

Prescription-style CBT app

85

out of 100

4.3/5

189 EUR / 90 days

Current Kalmeda Go shop price

3

Oto

Clinician-linked audio program

76

out of 100

3.8/5

No US pricing

US access is arranged through a participating provider

4

MindEar

Hybrid soundscape plus expert support

70

out of 100

3.5/5

$58.99 / year

Current US App Store annual plan

5

ReSound Relief

Sound-first tinnitus toolbox

58

out of 100

2.9/5

$69.99 / year

Current App Store annual plan

App breakdowns

How each app compares

These are short review summaries, not full hands-on reviews. Each card links the public sources used, shows the overall weighted score, and highlights the main reasons an app scored where it did.

Best overall

Reductinn

CBT-first self-management

Structured CBT-based tinnitus self-management with night support and source-checked evidence pages.

Overall score

98
/100
4.9/5

Ranked #1 overall

Reductinn scored highest in this scorecard because it combines a clearly structured CBT course, unusually transparent evidence pages, and the lowest straightforward paid entry point in this group. Its pricing also stands out because the current paid offer is a low one-time unlock rather than a recurring plan or a 90-day purchase window.

Use case

People who want the clearest evidence-first self-guided program they can start today on iPhone or Android.

Public pricing

$9.99

Current US App Store paid offer after 3 free days

Direct download on iPhone and Android. The first 3 days of content are free, and the current US App Store listing shows Reductinn Pro Offer at $9.99 as a one-time unlock.

Highest-scoring areas

Scientific basis
Evidence transparency
Program structure

Lower-scoring areas

Sound support
Progress tracking

Main tradeoff

The app has limited sound options and no daily reminders.

Structured CBT courseNight protocolsProgress trackingOne-time lifetime unlock
Reductinn home screen inside an iPhone frame

Reductinn in-app home screen reviewed on March 17, 2026.

Science note

Built around CBT-based education and exercises, which is the strongest evidence-supported feature family in this comparison.

Access note

Built for direct-to-consumer use in the US without a clinic gate, recurring subscription, or triple-digit upfront commitment.

Evidence note

Reductinn publishes a public research hub, a press page, and a dedicated CBT evidence page that make its claims easy to audit.

Best for sound masking

ReSound Relief

Sound-first tinnitus toolbox

A long-running sound therapy and relaxation app with customizable soundscapes and basic planning tools.

Strongest option here if sound masking and quick audio relief are the main priority.

Overall score

58
/100
2.9/5

Ranked #5 overall

ReSound Relief is not trying to be a CBT course. It is a long-running sound-therapy app, and that narrower focus is exactly why it stands out here for masking, layering soundscapes, and immediate audio relief. It ranks lower overall because the public evidence and program structure are lighter than the CBT-first apps.

Use case

People whose main need is immediate sound support, masking, and a free basic toolkit rather than a guided CBT course.

Public pricing

$69.99 / year

Current App Store annual plan

The current App Store listing shows Annual USD 69.99 and Monthly USD 6.99.

Highest-scoring areas

Sound support
Scientific basis
Price and access

Lower-scoring areas

Program structure
Evidence transparency

Main tradeoff

Public materials focus on sound therapy, relaxation, and meditation, which are useful but not as evidence-strong as CBT for tinnitus distress. ReSound also notes that the app is currently unavailable on Google Play.

Layered soundscapesFree basic versionRelaxation exercisesUsage tracking
ReSound Relief public product page

ReSound Relief public product page reviewed on March 17, 2026.

Science note

ReSound's core method is sound therapy plus relaxation, which is legitimate as a coping layer but does not help tinnitus as much as CBT-first approaches.

Access note

Easy to try on a smartphone, but it relies on recurring or annual billing for premium access and is unavailable for Android.

Evidence note

Public pages do a good job explaining features, but the evidence story is lighter and less source-forward than the highest-scoring apps.

Kalmeda

Prescription-style CBT app

A German DiGA-focused tinnitus app built around a formal CBT program with defined levels, stages, and reimbursement pathways.

Overall score

85
/100
4.3/5

Ranked #2 overall

Kalmeda has one of the clearest therapeutic structures in the set, with a formal CBT-style progression and strong medical framing. It scores well on science and structure, but its access story is much less straightforward for a typical user because the strongest path is still tied to Germany's DiGA or insurer route.

Use case

German users who want a prescription or insurer-backed CBT path and are comfortable with a more medical framing.

Public pricing

189 EUR / 90 days

Current Kalmeda Go shop price

The official Kalmeda shop lists Kalmeda Go at 189.00 EUR for 90 days.

Highest-scoring areas

Scientific basis
Evidence transparency
Program structure

Lower-scoring areas

Price and access
Progress tracking

Main tradeoff

Access is much less straightforward for a typical US user, and the public self-pay entry point is a high triple-digit 90-day price.

Formal CBT structurePeer-reviewed 3- and 9-month RCT results5 levels x 9 stagesSound library
Kalmeda public tinnitus app page

Kalmeda public product page reviewed on March 17, 2026.

Science note

Kalmeda is a CBT-based therapy with strong published product-specific evidence: one randomized trial of the Kalmeda app, with peer-reviewed 3-month results in PLOS Digital Health (2023) and a separately published 9-month follow-up in JMIR (2025). The trial reported a large effect at 3 months and improvement sustained at 9 months. It was company-sponsored and included product-affiliated authors.

Access note

Most practical for Germany-based users who can use the DiGA or insurer route. Much weaker immediate access for general US users.

Evidence note

Kalmeda's product-specific randomized trial and its 9-month follow-up are peer-reviewed and straightforward to verify, though its wider public source layer is less reader-friendly for English-speaking comparison shoppers.

Oto

Clinician-linked audio program

An audiologist-led tinnitus program that combines daily app sessions, behavior-change skills, and ongoing clinical care.

Overall score

76
/100
3.8/5

Ranked #3 overall

Oto presents itself as an audiologist-led tinnitus program with daily app sessions, behavior-change framing, and a strong emphasis on sleep-facing support. US residents cannot buy an Oto subscription directly and must receive access through a participating healthcare provider.

Use case

US users who want an audiologist-guided program and are comfortable arranging access through a participating clinic.

Public pricing

No US pricing

US access is arranged through a participating provider

Oto's terms say its subscription is not available to US residents. US users receive access through participating healthcare providers, so there is no standardized public US consumer price.

Highest-scoring areas

Scientific basis
Sleep and night support
Evidence transparency

Lower-scoring areas

Price and access
Progress tracking

Main tradeoff

Oto is not available as a direct-to-consumer subscription in the US; access and pricing must be arranged through a participating healthcare provider.

Daily audio sessionsAudiologist-led onboardingSleep-friendly audio formatRegistered RCT evidence
Oto public product page

Oto public product page; US access model rechecked on July 16, 2026.

Science note

Oto ties its product to CBT-based behavior change and has completed registered randomized trials of the app itself, including a published wait-list-controlled RCT and a large non-inferiority trial against one-to-one CBT (headline results pending peer review). As with the other product trials here, these are company-sponsored, but they remain strong, verifiable scientific positioning for Oto.

Access note

In the US, start with Oto's provider directory or a participating audiologist. The app may be listed in app stores, but the Oto subscription itself is not sold direct to US consumers.

Evidence note

Oto publishes a research page listing registered and peer-reviewed randomized trials of its own product, which a skeptic can verify directly.

MindEar

Hybrid soundscape plus expert support

A customizable tinnitus app that mixes soundscapes, chat, education, and optional expert appointments.

Overall score

70
/100
3.5/5

Ranked #4 overall

MindEar offers the broadest mix of soundscapes, education, chat, and optional expert support in this comparison. That flexibility makes it interesting for users who want a modular toolkit, but it also means a less structured therapeutic approach.

Use case

People who want flexible sound tools first and like the option of adding remote expert support later.

Public pricing

$58.99 / year

Current US App Store annual plan

The current US App Store listing shows multiple paid tiers, including MindEar Annual at $58.99, a $5.99 monthly plan, and higher-priced premium options.

Highest-scoring areas

Sound support
Scientific basis
Price and access

Lower-scoring areas

Sleep and night support
Progress tracking

Main tradeoff

The core product story is broader and less tightly structured than a CBT-first course, so the therapeutic arc is harder to verify from public pages.

Custom soundscapesOptional expert callsAI-powered positioningFree-trial entry point
MindEar public product page

MindEar public product page reviewed on March 17, 2026.

Science note

MindEar combines CBT, mindfulness, sound therapy, and AI-powered personalization. Its chatbot lineage has randomized-trial support: company-sponsored RCTs of the predecessor app, Tinnibot (Bardy et al. 2024; Jackson et al. 2026, 105 participants, waitlist-controlled), reported reduced tinnitus distress, anxiety, and depression. Those trials evaluated the earlier Tinnibot version rather than the current MindEar build.

Access note

Easy to start, especially for users who prefer trying an app before talking to a clinician, but the pricing model is recurring rather than a low one-time unlock.

Evidence note

MindEar's chatbot has published randomized trials to cite, but its consumer pages are more marketing-led than citation-led, so the therapeutic evidence is harder to verify at a glance.

Price comparison

What the pricing actually looks like

If you are choosing between these apps, the pricing model matters almost as much as the feature list. This is the practical version of what a typical user can expect.

AppPublic price reviewedBilling modelReviewer take

Reductinn

CBT-first self-management

$9.99

Current US App Store paid offer after 3 free days

One-time unlock

The simplest paid offer in this set: a low one-time unlock after the free intro, with no subscription to keep justifying.

MindEar

Hybrid soundscape plus expert support

$58.99 / year

Current US App Store annual plan

Monthly or annual subscription

Relatively approachable to start, but it is still a subscription product, so the value depends on whether you plan to keep using it.

ReSound Relief

Sound-first tinnitus toolbox

$69.99 / year

Current App Store annual plan

Monthly or annual subscription

Reasonable if your main need is sound masking, but premium access still pushes you into recurring billing.

Oto

Clinician-linked audio program

No US pricing

US access is arranged through a participating provider

Access through a participating provider

Oto does not sell a consumer subscription to US residents. Access and pricing are arranged through a participating audiologist or hearing clinic.

Kalmeda

Prescription-style CBT app

189 EUR / 90 days

Current Kalmeda Go shop price

90-day purchase

Clear structure, but the public self-pay route is the biggest upfront commitment in the group.

Why Reductinn's pricing stands out

From a reviewer's standpoint, Reductinn is the easiest paid option here to recommend on price alone. It asks for a small one-time unlock instead of a subscription or a short-term 90-day purchase, which lowers the risk of trying it and makes it easier to come back later without another buying decision.

How we reviewed

What this scorecard rewards

We reviewed public product pages, public help pages, App Store listings, and linked research or evidence pages available on July 21, 2026. If a claim could not be verified from public materials, it did not help the score. The weights below reflect this page's focus: evidence-first, self-guided tinnitus relief.

Scientific basis

25% of total

How well the app's core method lines up with the strongest tinnitus evidence. Structured CBT gets the highest marks because it has the best randomized-trial support for reducing tinnitus distress. This factor scores how closely a method aligns with that evidence base, not whether the individual app has been tested in its own clinical trial.

Evidence transparency

15% of total

How easy it is for a skeptic to verify the product's claims on public pages before downloading.

Program structure

15% of total

Whether the app feels like a guided program with progression, milestones, and a clear therapeutic arc instead of an unstructured tool bucket.

Sleep and night support

10% of total

How directly the app addresses nighttime distress, bedtime routines, and sleep disruption, which is a major tinnitus pain point.

Sound support

10% of total

How strong the app's sound masking, soundscape, or sound-enrichment toolkit is when users need immediate relief in difficult moments.

Progress tracking

10% of total

How clearly the app surfaces progress, goal completion, questionnaires, or usage patterns so users can see movement over time.

Price and access

15% of total

How affordable and easy it is to start today without clinic gatekeeping, insurer paperwork, or unclear pricing.

FAQ

Common comparison questions

Which tinnitus app has the strongest scientific basis?

Several apps here have their own trials showing efficacy for tinnitus relief. Kalmeda has strong published product evidence from one peer-reviewed RCT, with separate publications reporting the 3-month comparison and 9-month follow-up; Oto has a published wait-list RCT plus a Cambridge-led non-inferiority trial vs one-to-one CBT, with results pending peer review. MindEar has randomized-trial evidence from its predecessor app, Tinnibot, and ReSound has clinical study data. Reductinn faithfully delivers the CBT method with the best overall evidence for tinnitus distress but hasn't yet published a trial of the Reductinn app itself — so on product-specific trials, Kalmeda and Oto lead. Most of these product trials are company-sponsored and include product-affiliated authors, which is common in this field and worth keeping in mind.

Is CBT better supported than sound therapy for tinnitus?

For tinnitus distress, yes. Sound therapy can be useful, especially for immediate relief or sleep, but the strongest evidence still favors CBT-based approaches for long-term coping and burden reduction.

Why does cost and access matter in this ranking?

Because the best app on paper is not helpful if a user cannot realistically start. We score whether someone can download the app, understand the pricing model, and begin without clinic or insurer friction.

Which tinnitus app is the cheapest to start?

Among the apps with a public US consumer price in the sources reviewed on March 17, 2026, Reductinn had the lowest clear upfront paid offer in this set at $9.99 on the US App Store. Kalmeda's shop listed 189.00 EUR for 90 days, while MindEar and ReSound used recurring or annual pricing. Oto's US access model was rechecked on July 16, 2026: it does not offer a direct-to-consumer subscription to US residents, so access and pricing must be arranged through a participating healthcare provider.